182 related articles for article (PubMed ID: 18987279)
1. Impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women: do we need a new drug?
Legro RS
J Clin Endocrinol Metab; 2008 Nov; 93(11):4218-20. PubMed ID: 18987279
[No Abstract] [Full Text] [Related]
2. The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials.
Hoeger K; Davidson K; Kochman L; Cherry T; Kopin L; Guzick DS
J Clin Endocrinol Metab; 2008 Nov; 93(11):4299-306. PubMed ID: 18728175
[TBL] [Abstract][Full Text] [Related]
3. Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin.
Harris-Glocker M; Davidson K; Kochman L; Guzick D; Hoeger K
Fertil Steril; 2010 Feb; 93(3):1016-9. PubMed ID: 19781696
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness of metformin, oral contraceptives, and lifestyle modification in improving the metabolism of overweight women with polycystic ovary syndrome: a network meta-analysis.
Wang A; Mo T; Li Q; Shen C; Liu M
Endocrine; 2019 May; 64(2):220-232. PubMed ID: 30911997
[TBL] [Abstract][Full Text] [Related]
5. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.
Tang T; Glanville J; Hayden CJ; White D; Barth JH; Balen AH
Hum Reprod; 2006 Jan; 21(1):80-9. PubMed ID: 16199429
[TBL] [Abstract][Full Text] [Related]
6. Effect of 12-month treatment with metformin and/or oral contraceptives on health-related quality of life in polycystic ovary syndrome.
Altinok ML; Ravn P; Andersen M; Glintborg D
Gynecol Endocrinol; 2018 Oct; 34(10):859-863. PubMed ID: 29658344
[TBL] [Abstract][Full Text] [Related]
7. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.
Hoeger KM; Kochman L; Wixom N; Craig K; Miller RK; Guzick DS
Fertil Steril; 2004 Aug; 82(2):421-9. PubMed ID: 15302293
[TBL] [Abstract][Full Text] [Related]
8. Optimal management of polycystic ovary syndrome in adolescence.
Hecht Baldauff N; Arslanian S
Arch Dis Child; 2015 Nov; 100(11):1076-83. PubMed ID: 26101431
[TBL] [Abstract][Full Text] [Related]
9. Effect of rimonabant and metformin on glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 in obese women with polycystic ovary syndrome.
Sathyapalan T; Cho L; Kilpatrick ES; Le Roux CW; Coady AM; Atkin SL
Clin Endocrinol (Oxf); 2010 Mar; 72(3):423-5. PubMed ID: 19489873
[No Abstract] [Full Text] [Related]
10. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.
Chou KH; von Eye Corleta H; Capp E; Spritzer PM
Horm Metab Res; 2003 Feb; 35(2):86-91. PubMed ID: 12734787
[TBL] [Abstract][Full Text] [Related]
11. Metformin for the treatment of the polycystic ovary syndrome.
Barbieri RL; Gargiulo AR
Minerva Ginecol; 2004 Feb; 56(1):63-79. PubMed ID: 14973411
[TBL] [Abstract][Full Text] [Related]
12. [Evidence-based therapy of polycystic ovarian syndrome].
Gődény S; Csenteri OK
Orv Hetil; 2015 Nov; 156(45):1803-15. PubMed ID: 26551444
[TBL] [Abstract][Full Text] [Related]
13. Effect of lifestyle modification and metformin therapy on emerging cardiovascular risk factors in overweight Indian women with polycystic ovary syndrome.
Rajagopal G; Reddy AP; Venkata Harinarayan C; Suresh V; Bitla A; P V L N Rao S; Sachan A
Metab Syndr Relat Disord; 2012 Aug; 10(4):273-9. PubMed ID: 22468948
[TBL] [Abstract][Full Text] [Related]
14. Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy.
Diamanti-Kandarakis E; Spina G; Kouli C; Migdalis I
J Clin Endocrinol Metab; 2001 Oct; 86(10):4666-73. PubMed ID: 11600523
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone reduces androgen levels in metformin-treated patients with polycystic ovary syndrome.
Vanky E; Kjøtrød SB; Maesel A; Bjerve KS; Carlsen SM
Fertil Steril; 2004 Feb; 81(2):459-62. PubMed ID: 14967392
[TBL] [Abstract][Full Text] [Related]
16. [When and how should polycystic ovary syndrome be treated?].
Martikainen H
Duodecim; 2001; 117(13):1323-7; quiz 1327, 1341. PubMed ID: 12184121
[No Abstract] [Full Text] [Related]
17. Insulin-sensitizing agents in polycystic ovary syndrome.
Pasquali R; Gambineri A
Eur J Endocrinol; 2006 Jun; 154(6):763-75. PubMed ID: 16728533
[TBL] [Abstract][Full Text] [Related]
18. Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking.
Luque-Ramírez M; Mendieta-Azcona C; del Rey Sánchez JM; Matíes M; Escobar-Morreale HF
Eur J Endocrinol; 2009 Mar; 160(3):469-80. PubMed ID: 19139031
[TBL] [Abstract][Full Text] [Related]
19. Use of metformin in polycystic ovary syndrome: a meta-analysis.
Creanga AA; Bradley HM; McCormick C; Witkop CT
Obstet Gynecol; 2008 Apr; 111(4):959-68. PubMed ID: 18378757
[TBL] [Abstract][Full Text] [Related]
20. Impact of metformin on anti-Müllerian hormone in women with polycystic ovary syndrome: a secondary analysis of a randomized controlled trial.
Madsen HN; Lauszus FF; Trolle B; Ingerslev HJ; Tørring N
Acta Obstet Gynecol Scand; 2015 May; 94(5):547-51. PubMed ID: 25736975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
